Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population

Ding Yin-man; Zhang Xin-ji; Li Jing-Ping; Chen San-san; Zhang Ren-tao; Tan Wan-long; Shi Xiao-Jun

首页> 外文期刊>Clinical Endocrinology >Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population

【24h】

Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population

机译：重组人卵泡刺激素治疗特发性少精子症：一项针对中国人群的前瞻性，随机，双盲，安慰剂对照临床研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective Follicle-stimulating hormone plays a crucial role in spermatogenesis. The aim of this study was to evaluate the efficacy of treatment with FSH in Chinese infertility population.

机译：目的促卵泡激素在精子发生中起关键作用。这项研究的目的是评估FSH治疗中国不育人群的疗效。

著录项

来源
《Clinical Endocrinology》 |2015年第6期|共6页
作者
Ding Yin-man; Zhang Xin-ji; Li Jing-Ping; Chen San-san; Zhang Ren-tao; Tan Wan-long; Shi Xiao-Jun;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population [J] . Ding Yin-man, Zhang Xin-ji, Li Jing-Ping, Clinical Endocrinology . 2015,第6期

机译：重组人卵泡刺激素治疗特发性少精子症：一项针对中国人群的前瞻性，随机，双盲，安慰剂对照临床研究
2. Treatment of idiopathic oligozoospermia with combined human chorionic gonadotropin/human menopausal gonadotrophin: A randomised, double-blinded, placebo-controlled clinical study [J] . Zhao Nan, Lu Xi-Lan, Li Jun-Tao, Andrologia . 2019,第6期

机译：用组合人绒毛膜促性腺激素/人寿期促性腺激素患者治疗特发性少血清蛋白：随机，双盲，安慰剂控制临床研究
3. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: A randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone. [J] . Bell W, Davies JS, Evans WD, American journal of human biology: the official journal of the Human Biology Council . 2004,第5期

机译：生长激素缺乏症的躯体特征和心血管危险因素：重组人生长激素治疗效果的随机，双盲，安慰剂对照研究。
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial [O] . Lexun Wang, Lei Xiang, Shenghua Piao, 2021

机译：中医福芳镇松河胶囊（FTZ）治疗糖尿病冠心病的疗效和安全性：多中心随机双盲安慰剂对照临床试验研究方案
7. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial [O] . A. Kamischke, H. M. Behre, M. Bergmann, 1998

机译：重组人卵泡刺激激素治疗男性特发性不孕症：随机，双盲，安慰剂控制，临床试验

Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population

摘要

著录项

相似文献

相关主题

期刊订阅